TY - JOUR
T1 - HIV serostatus knowledge and serostatus disclosure with the most recent anal intercourse partner in a European MSM sample recruited in 13 cities
T2 - Results from the Sialon-II study
AU - Marcus, Ulrich
AU - Schink, Susanne Barbara
AU - Sherriff, Nigel
AU - Jones, Anna Marie
AU - Gios, Lorenzo
AU - Folch, Cinta
AU - Berglund, Torsten
AU - Nöstlinger, Christiana
AU - Niedźwiedzka-Stadnik, Marta
AU - Dias, Sonia F.
AU - Gama, Ana F.
AU - Naseva, Emilia
AU - Alexiev, Ivailo
AU - Staneková, Danica
AU - Toskin, Igor
AU - Pitigoi, Daniela
AU - Rafila, Alexandru
AU - Klavs, Irena
AU - Mirandola, Massimo
AU - SIALON II Network
A2 - Benvenuti, Stefano
A2 - Davis, Ruth Joanna
A2 - Lunardi, Massimo
A2 - Menichelli, Silvana
A2 - Breveglieri, Michele
A2 - Furegato, Martina
A2 - Berghe, Wim Vanden
A2 - de Groot, Peter
A2 - Christiana Nöstlinger, Nöstlinger
A2 - van Wijk, Veronica
A2 - Fransen, Katrien
A2 - Vermoesen, Tine
A2 - Vanackere, Michiel
A2 - Benchikha, Fourat
A2 - Van den Eynde, Sandra
A2 - Cruyssaert, Boris
A2 - Sergeant, Mark
A2 - Blondeel, Karel
A2 - Damen, Pieter
A2 - Massoz, François
A2 - Carlier, Erwin
A2 - François, Michael
A2 - Karon, Stephen
A2 - Dieleman, Myriam
A2 - Dimitrova, Reneta
A2 - Gancheva, Anna
A2 - Dudareva-Vizule, Sandra
N1 - Publisher Copyright:
© 2017 The Author(s).
PY - 2017/11/25
Y1 - 2017/11/25
N2 - Background: Knowledge of HIV status can be important in reducing the risk of HIV exposure. In a European sample of men-who-have-sex-with-men (MSM), we aimed to identify factors associated with HIV serostatus disclosure to the most recent anal intercourse (AI) partner. We also aimed to describe the impact of HIV serostatus disclosure on HIV exposure risks. Methods: During 2013 and 2014, 4901 participants were recruited for the bio-behavioural Sialon-II study in 13 European cities. Behavioural data were collected with a self-administered paper questionnaire. Biological specimens were tested for HIV antibodies. Factors associated with HIV serostatus disclosure with the most recent AI partner were examined using bivariate and multilevel multivariate logistic regression analysis. We also describe the role of serostatus disclosure for HIV exposure of the most recent AI partner. Results: Thirty-five percent (n = 1450) of the study participants reported mutual serostatus disclosure with their most recent AI partner or disclosed having HIV to their partner. Most of these disclosures occurred between steady partners (74%, n = 1077). In addition to the type of partner and HIV diagnosis status, other factors positively associated with HIV serostatus disclosure in the multilevel multivariate logistic regression model were recent testing, no condom use, and outness regarding sexual orientation. Disclosure rates were lowest in three south-eastern European cities. Following condom use (51%, n = 2099), HIV serostatus disclosure (20%, n = 807) was the second most common prevention approach with the most recent AI partner, usually resulting in serosorting. A potential HIV exposure risk for the partner was reported by 26% (111/432) of HIV antibody positive study participants. In 18% (20/111) of exposure episodes, an incorrect HIV serostatus was unknowingly communicated. Partner exposures were equally distributed between steady and non-steady partners. Conclusions: The probability of HIV exposure through condomless AI is substantially lower after serostatus disclosure compared to non-disclosure. Incorrect knowledge of one's HIV status contributes to a large proportion of HIV exposures amongst European MSM. Maintaining or improving condom use for anal intercourse with non-steady partners, frequent testing to update HIV serostatus awareness, and increased serostatus disclosure particularly between steady partners are confirmed as key aspects for reducing HIV exposures amongst European MSM.
AB - Background: Knowledge of HIV status can be important in reducing the risk of HIV exposure. In a European sample of men-who-have-sex-with-men (MSM), we aimed to identify factors associated with HIV serostatus disclosure to the most recent anal intercourse (AI) partner. We also aimed to describe the impact of HIV serostatus disclosure on HIV exposure risks. Methods: During 2013 and 2014, 4901 participants were recruited for the bio-behavioural Sialon-II study in 13 European cities. Behavioural data were collected with a self-administered paper questionnaire. Biological specimens were tested for HIV antibodies. Factors associated with HIV serostatus disclosure with the most recent AI partner were examined using bivariate and multilevel multivariate logistic regression analysis. We also describe the role of serostatus disclosure for HIV exposure of the most recent AI partner. Results: Thirty-five percent (n = 1450) of the study participants reported mutual serostatus disclosure with their most recent AI partner or disclosed having HIV to their partner. Most of these disclosures occurred between steady partners (74%, n = 1077). In addition to the type of partner and HIV diagnosis status, other factors positively associated with HIV serostatus disclosure in the multilevel multivariate logistic regression model were recent testing, no condom use, and outness regarding sexual orientation. Disclosure rates were lowest in three south-eastern European cities. Following condom use (51%, n = 2099), HIV serostatus disclosure (20%, n = 807) was the second most common prevention approach with the most recent AI partner, usually resulting in serosorting. A potential HIV exposure risk for the partner was reported by 26% (111/432) of HIV antibody positive study participants. In 18% (20/111) of exposure episodes, an incorrect HIV serostatus was unknowingly communicated. Partner exposures were equally distributed between steady and non-steady partners. Conclusions: The probability of HIV exposure through condomless AI is substantially lower after serostatus disclosure compared to non-disclosure. Incorrect knowledge of one's HIV status contributes to a large proportion of HIV exposures amongst European MSM. Maintaining or improving condom use for anal intercourse with non-steady partners, frequent testing to update HIV serostatus awareness, and increased serostatus disclosure particularly between steady partners are confirmed as key aspects for reducing HIV exposures amongst European MSM.
KW - Bio-behavioural survey
KW - HIV exposure
KW - HIV serostatus disclosure
KW - Men who have sex with men
UR - http://www.scopus.com/inward/record.url?scp=85035030031&partnerID=8YFLogxK
U2 - 10.1186/s12879-017-2814-x
DO - 10.1186/s12879-017-2814-x
M3 - Article
C2 - 29178847
AN - SCOPUS:85035030031
SN - 1471-2334
VL - 17
JO - BMC Infectious Diseases
JF - BMC Infectious Diseases
IS - 1
M1 - 730
ER -